SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alivus Life Sciences submits intimation of 14th AGM and record date

11 Aug 2025 Evaluate
Alivus Life Sciences has informed that the Fourteenth (14th) Annual General Meeting (‘AGM’) of the Company will be held on Monday, September 8, 2025, at 03:00 pm (IST) through Video Conferencing (‘VC’) or Other Audio-Visual Means (‘OAVM’), in accordance, with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India (‘SEBI’). As informed earlier, the Board of Directors at its meeting held on May 15, 2025, had recommended a final dividend of Rs 5.00 per Equity share of Rs 2 each of the Company for the financial year ended March 31, 2025, for approval by the shareholders at the AGM. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company has fixed Monday, September 1, 2025, as the ‘Record Date’ for the purpose of determining the entitlement of Members to receive the aforesaid dividend for the financial year ended March 31, 2025. If the aforesaid dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on or after Friday, September 12, 2025. This will also be posted on the company’s website www.alivus.com

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

1059.20 12.70 (1.21%)
15-Apr-2026 10:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.80
Dr. Reddys Lab 1216.00
Cipla 1225.45
Zydus Lifesciences 931.00
Lupin 2336.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×